USANA Health Sciences (NYSE:USNA – Get Free Report) released its quarterly earnings data on Tuesday. The company reported $0.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.15, Zacks reports. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. USANA Health Sciences updated its FY 2025 guidance to 2.350-3.000 EPS.
USANA Health Sciences Trading Down 2.4 %
USNA stock traded down $0.79 during midday trading on Tuesday, reaching $31.90. 439,914 shares of the company’s stock traded hands, compared to its average volume of 145,126. USANA Health Sciences has a 52-week low of $30.13 and a 52-week high of $50.32. The stock has a market cap of $607.96 million, a P/E ratio of 11.27, a PEG ratio of 0.93 and a beta of 0.87. The stock’s 50-day moving average is $33.73 and its 200 day moving average is $36.68.
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on the stock. DA Davidson raised their price target on shares of USANA Health Sciences from $35.00 to $38.00 and gave the company a “neutral” rating in a report on Thursday, January 2nd. Sidoti cut shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 18th. Finally, StockNews.com downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th.
About USANA Health Sciences
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
See Also
- Five stocks we like better than USANA Health Sciences
- What is the S&P/TSX Index?
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Find and Profitably Trade Stocks at 52-Week Lows
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.